56962-13-1 Usage
Uses
Used in Pharmaceutical Industry:
2,4-dichloro-3-hydroxybenzaldehyde is used as an intermediate in the synthesis of various pharmaceuticals for its ability to undergo multiple chemical reactions, contributing to the development of new drugs.
Used in Agrochemical Industry:
DHB is utilized as an intermediate in the production of agrochemicals, where its chemical reactivity plays a crucial role in creating effective compounds for agricultural applications.
Used in Antimicrobial Applications:
2,4-dichloro-3-hydroxybenzaldehyde is used as an antimicrobial agent due to its reported antimicrobial properties, which can be harnessed to combat various microbial infections.
Used in Anticancer Research:
DHB is used as a potential anticancer agent in research settings, given its demonstrated anticancer properties, and is explored for its ability to contribute to the development of new cancer treatments.
Used in Chemical Synthesis:
As a versatile building block, 2,4-dichloro-3-hydroxybenzaldehyde is used in the synthesis of diverse organic compounds, owing to its capacity to engage in a range of chemical reactions, thus expanding the scope of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 56962-13-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,9,6 and 2 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 56962-13:
(7*5)+(6*6)+(5*9)+(4*6)+(3*2)+(2*1)+(1*3)=151
151 % 10 = 1
So 56962-13-1 is a valid CAS Registry Number.
56962-13-1Relevant articles and documents
Novel Compounds Active as Muscarinic Receptor Antagonists
-
Page/Page column 15, (2010/02/17)
The invention relates to compounds of formula [image] processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical compositions containing them.
NOVEL COMPOUNDS ACTIVE AS MUSCARINIC RECEPTOR ANTAGONISTS
-
Page/Page column 26, (2010/04/03)
The invention relates to compounds of formula (I), processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical compositions containing them.
